Integer Holdings Co. (NYSE:ITGR) Shares Purchased by Raymond James & Associates

Raymond James & Associates grew its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 5.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 52,496 shares of the medical equipment provider’s stock after purchasing an additional 2,848 shares during the period. Raymond James & Associates’ holdings in Integer were worth $6,079,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Cerity Partners LLC acquired a new position in Integer during the fourth quarter worth $208,000. Strs Ohio grew its stake in shares of Integer by 54.5% during the 4th quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider’s stock worth $168,000 after purchasing an additional 600 shares during the period. Mackenzie Financial Corp purchased a new position in shares of Integer in the 4th quarter valued at about $204,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Integer by 16.8% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,724 shares of the medical equipment provider’s stock valued at $567,000 after purchasing an additional 822 shares during the period. Finally, Handelsbanken Fonder AB boosted its holdings in Integer by 1.7% during the fourth quarter. Handelsbanken Fonder AB now owns 5,837 shares of the medical equipment provider’s stock worth $578,000 after buying an additional 100 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Oppenheimer assumed coverage on shares of Integer in a research report on Tuesday, July 16th. They set an “outperform” rating and a $135.00 price target for the company. Benchmark reiterated a “buy” rating and set a $130.00 target price on shares of Integer in a research report on Friday, August 2nd. Citigroup upped their target price on Integer from $118.00 to $124.00 and gave the company a “neutral” rating in a report on Wednesday, May 22nd. Finally, Truist Financial assumed coverage on Integer in a research note on Wednesday, May 15th. They set a “buy” rating and a $137.00 price target for the company. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, Integer currently has a consensus rating of “Moderate Buy” and a consensus price target of $133.86.

Integer Stock Performance

Integer stock opened at $127.26 on Wednesday. Integer Holdings Co. has a fifty-two week low of $69.40 and a fifty-two week high of $130.15. The company has a market capitalization of $4.26 billion, a price-to-earnings ratio of 44.03, a PEG ratio of 1.70 and a beta of 1.11. The stock has a fifty day moving average of $118.65 and a two-hundred day moving average of $115.82. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.06. The company had revenue of $436.20 million during the quarter, compared to the consensus estimate of $437.00 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. Integer’s revenue was up 9.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.14 EPS. On average, analysts anticipate that Integer Holdings Co. will post 5.31 EPS for the current fiscal year.

Insider Buying and Selling at Integer

In other Integer news, EVP John A. Harris sold 1,521 shares of the business’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $120.44, for a total value of $183,189.24. Following the completion of the transaction, the executive vice president now directly owns 4,922 shares in the company, valued at approximately $592,805.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Jean M. Hobby sold 11,960 shares of the company’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the sale, the director now directly owns 2,280 shares in the company, valued at approximately $272,824.80. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP John A. Harris sold 1,521 shares of the company’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $120.44, for a total value of $183,189.24. Following the sale, the executive vice president now owns 4,922 shares of the company’s stock, valued at $592,805.68. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by insiders.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.